Lille University hosiptal
Welcome,         Profile    Billing    Logout  
 27 Trials 
33 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HACHULLA, Eric
BE-EARLY, NCT06411249: A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Recruiting
4
350
Europe, Japan, US, RoW
Belimumab (GSK1550188), BEL (BENLYSTA)
GlaxoSmithKline
Systemic Lupus Erythematosus
04/27
05/29
BEconneCTD-ILD, NCT06572384: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Recruiting
3
440
Europe, Canada, Japan, US, RoW
Belimumab, BENLYSTA, GSK1550188, Placebo
GlaxoSmithKline
Lung Diseases, Interstitial
10/28
12/28
NCT04781543 / 2020-005764-62: A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis

Calendar Jan 2024 - Dec 2024: Data from trial for diffuse cutaneous systemic sclerosis
Active, not recruiting
2/3
301
Europe, Japan, US, RoW
HZN-825 BID, Placebo, HZN-825 QD
Amgen, Horizon Therapeutics USA, Inc
Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic
09/25
09/25
ADUSE, NCT04356755: Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.

Recruiting
2
32
Europe
AdMSC, Placebo
University Hospital, Toulouse
Systemic Sclerosis
12/25
12/25
NECESSITY, NCT05113004: New Clinical End-points in Patients With Primary Sjögren's Syndrome

Recruiting
2
300
Europe
Hydroxychloroquine 400mg/d, Leflunomide 20mg/d, Mycophenolate mofetil 2000mg/d, Placebo of Hydroxychloroquine 400mg/d, Placebo of Leflunomide 20mg/d, Placebo of Mycophenolate mofetil 2000mg/d
Assistance Publique - Hôpitaux de Paris
Primary Sjögren's Syndrome (pSS)
04/25
10/25
TRIBECA, NCT04629144: Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)

Recruiting
2
48
Europe
Belimumab, Placebo
Assistance Publique - Hôpitaux de Paris
Vasculitis, Cryoglobulinemia
04/25
10/25
SCLERITA, NCT04789850: Safety and Efficacy of Itacitinib in Adults with Systemic Sclerosis

Recruiting
2
74
Europe
Itacitinib, Placebo
Assistance Publique - Hôpitaux de Paris
Systemic Sclerosis
02/26
02/26
PREVASCLERO, NCT04363021: Is a History of Pre-eclampsia a Risk Factor for Vascular Phenotype in Women With Systemic Sclerosis?

Completed
N/A
378
Europe
University Hospital, Brest
Systemic Sclerosis, Preeclampsia, Vascular Complications
05/22
05/22
SATORI, NCT05022420: SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases

Recruiting
N/A
600
Europe
University Hospital, Brest
Tolerance, Biopsy Site Itching
02/25
02/25
MAINEPSAN, NCT03290456: Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.

Recruiting
N/A
146
Europe
Prednisone 5mg/day extended of 12 additional months, Placebo 5mg/day extended of 12 additionnal months.
Hospices Civils de Lyon
Granulomatosis With Polyangitis
06/24
06/24
ISLE, NCT04276701: Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases

Recruiting
N/A
500
Europe
blood sample, Ultrasonography assessment, questionnaires
University Hospital, Bordeaux, Foundation for Research in Rheumatology (FOREUM)
Systemic Lupus Erythematosus
03/27
03/27
APSregistry, NCT04308564: Laboratory and Clinical Data in Antiphospholipid Patients

Recruiting
N/A
60
Europe
Blood test
Central Hospital, Nancy, France
Antiphospholipid Syndrome
04/30
04/31
VERMERSCH, Patrick
MASIMS, NCT05441488 / 2021-000639-30: Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

Recruiting
3
800
Europe, RoW
Placebo, Placebo Oral Tablet, Masitinib (4.5), AB1010
AB Science
Progressive Multiple Sclerosis
12/25
12/25
CONSONANCE EXT, NCT05210621: LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB

Active, not recruiting
3
72
Europe
Ocrelizumab
Centre Hospitalier Universitaire de Nice
Multiple Sclerosis
02/26
02/29
MS-DETECT, NCT05816122: Early Detection of Multiple Sclerosis Progression with MSCopilot® Detect

Recruiting
N/A
314
Europe, Canada, US
MSCopilot® Detect mobile application
Ad scientiam
Multiple Sclerosis
12/26
12/26
RESPONSE, NCT03900221: French Registry for Monitoring Pregnancies for Multiple Sclerosis

Recruiting
N/A
1000
Europe, RoW
No intervention
Hospices Civils de Lyon
Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders, Pregnancy Abnormal
08/36
08/36
Launay, David
SCLERO-PRL, NCT04746313: Prevalence of Hyperprolactinemia in Systemic Scleroderma

Recruiting
N/A
200
Europe
blood test
University Hospital, Lille, Association pour la Formation et la Recherche en Médecine Interne (AFORMI)
Sclerosis, Systemic, Scleroderma, Hyperprolactinemia
03/23
03/23
SCLERO-LB, NCT03559465: Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.

Recruiting
N/A
71
Europe
skin biopsy, Blood punction
University Hospital, Lille
Scleroderma, Systemic
12/23
12/23
SCLERONAB, NCT06412614: Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies

Not yet recruiting
N/A
300
Europe
disease phenotype
Central Hospital, Nancy, France
Systemic Sclerosis
06/25
06/25
SCLERO-PID, NCT03271333: Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.

Recruiting
N/A
70
Europe
lung function tests
University Hospital, Lille
Systemic Sclerosis
04/25
04/25
KIN-ACE, NCT04763577: Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema

Recruiting
N/A
243
Europe
Assay of Bradykinin-degradating enzymes.
University Hospital, Grenoble, University Hospital, Paris, University Hospital, Rouen
Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
04/25
04/25
Skin-SSC, NCT05273138: Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis

Recruiting
N/A
40
Europe
Blood sampling and skin biopsy
University Hospital, Lille
Systemic Sclerosis
07/25
07/25
BRADYDIAG, NCT04963634: Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin Angioedema

Recruiting
N/A
110
Europe
Biobanking, Biobanking without genetic analysis
University Hospital, Lille
Angio Edema
01/26
01/26
NCT01034969: Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

Completed
N/A
1761
Europe, RoW
Shire, Takeda Development Center Americas, Inc.
Hereditary Angioedema (HAE)
05/24
05/24
IMMINeNT, NCT04334031: Deployment o the Multidisciplinary Prospective Cohort Imminent

Recruiting
N/A
2200
Europe
Biobanking with genetic analysis, SF-12 questionnaire
University Hospital, Lille, FHU IMMINeNT, FHU PRECISE: Projet Fédératif Hospitalo-Universitaire PREcision health in Complex Immune-mediated inflammatory diseaSEs, Fond de dotation de la Société Française de Dermatologie (SFD)
Chronic Inflammatory Disease, Angioedema, Severe Asthma, Lupus, Atopic Dermatitis, Psoriatic Arthritis, Multiple Sclerosis, Systemic Sclerosis, Behçet Disease
07/31
07/31
SCLERO-BIOBANK, NCT04986514: Implementation of a Biological Sample Collection in Systemic Sclerosis Patients

Not yet recruiting
N/A
1000
NA
Bio-banking without genetic analysis
University Hospital, Lille
Systemic Sclerosis
04/43
04/43
Zephir, Helene
MOGwAI, NCT05349006: Azathioprine in MOGAD

Not yet recruiting
3
126
Europe
Azathioprine, Placebo
Hospices Civils de Lyon
Central Nervous System Inflammation, MOG-IgG Associated Disease
01/26
01/29
NCT03958877 / 2018-003008-38: A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

Active, not recruiting
3
142
Europe, US, RoW
BIIB017 (peginterferon beta-1a), PLEGRIDY, Interferon beta type 1a, Avonex
Biogen
Multiple Sclerosis, Relapsing-Remitting
05/27
05/27
MSST, NCT04595799: Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.

Active, not recruiting
N/A
240
Europe
Centre Hospitalier Universitaire de Nice
Multiple Sclerosis
11/25
11/25
BABYZUMAB-2, NCT05209815: Safety of Exposure to Natalizumab During Pregnancy

Completed
N/A
68
Europe, RoW
Questionnaire
University Hospital, Bordeaux, Biogen
Multiple Sclerosis
12/23
12/23
OPTIS, NCT05566769: Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

Recruiting
N/A
103
Europe, US
NMOSDCopilot smartphone application
Ad scientiam
Neuromyelitis Optica
04/25
04/26
NeurofilMS, NCT03981003: Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

Recruiting
N/A
1150
Europe, RoW
Blood sample
Centre Hospitalier Universitaire de Nīmes, Hospices Civils de Lyon
Multiple Sclerosis
06/28
06/28
Moroni, Christine
PROMESSE, NCT03975959: Memory Perception Assessment in Central/Non-central Nervous System Cancers

Active, not recruiting
N/A
426
Europe
QMRP questionnaire, HADS questionnaire, MFI questionnaire, MOCA test, FAB test
Institut du Cancer de Montpellier - Val d'Aurelle
Glioblastoma, Glioma, Breast Cancer, Healthy
06/24
10/24
Delbeucq, Xavier
No trials found
Pruvo, Jean-Pierre
No trials found
Henichart, Camille
No trials found
Jissendi, Patrice
No trials found

Download Options